Evidence map›Paper›PMID 39559491›Full record

ArticleJAMIA open2024

Implementation of a rule-based algorithm to find patients eligible for cancer clinical trials.

Nina A Bickell, Benjamin May, Ihor Havrylchuk, Jimmy John, Sylvia Lin, Ariana Tao, Radhi Yagnik, Nicholas P Tatonetti

Registry-linked trialAbstract read
In one paragraph

Article in JAMIA open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05146297 (Diversity and Inclusion in Research Underpinning Trials), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05146297 nacompletednot on this map

Diversity and Inclusion in Research Underpinning Trials

TypeinterventionalSponsorIcahn School of Medicine at Mount SinaiRan2023 to 2026Enrolled585ConditionsBreast Cancer, Liver Cancer, Prostate CancerArmsClinical trial match-list, Match-list intervention
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. AI-based augmentation of oncology clinical trials.Nature reviews. Clinical oncology · 2026
    Review
  2. Article
  3. Article
  4. Recommending Clinical Trials for Online Patient Cases using Artificial Intelligence.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nina A BickellInstitute for Health Equity Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, United States.ORCID https://orcid.org/0000-0003-1102-8677
Benjamin MayHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, United States.
Ihor HavrylchukDepartment of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, United States.
Jimmy JohnMontefiore Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Sylvia LinInstitute for Health Equity Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, United States.
Ariana TaoMontefiore Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, United States.
Radhi YagnikInstitute for Health Equity Research, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York City, NY 10029, United States.
Nicholas P TatonettiHerbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY 10032, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To explore implementing regular expressions (RegEx) to streamline patient identification and classification for matching to clinical trials. Materials and Methods: To prepare approaches needed to match patients to relevant cancer clinical trials, we combined NCI's Clinical Trials Search API to extract high-level eligibility criteria, including cancer type, stage, receptor/biomarker status, with similar data of patients with appointments in the upcoming week. Using RegEx, we prospectively identified all patients with breast, liver, or lung cancers at treatment decision points at 2 Cancer Centers' and 2 community hospitals', classified their cancer type, stage, and receptor/biomarker status. We evaluated accuracy using RegEx against manual reviews. Results: Algorithm accuracy to identify patients at treatment decision points revealed 92% True Negative and 53% True Positive rate. Staging accuracy varied from 67% to 95%, and receptor/biomarker status accuracy from 76% to 86%. Discussion and Conclusion: Using RegEx significantly reduced the number of patients requiring manual review, demonstrating a reduction in manual labor and potential biases, which can improve efficiency and inclusivity of clinical trial enrollment processes, especially in resource limited or data sensitive environments. Trial Registration: NCT05146297.

Indexed as

algorithmscancer clinical trialsracial disparitiesregular expressions

Identifiers

PMID39559491
PMCPMC11570988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.